✨
AI Summary
- Albert Bourla discusses Pfizer's drug development process, the company's scale, and challenges in pharmaceutical innovation
- Covers rapid COVID-19 vaccine development, regulatory approval processes, and managing public perception of pharmaceutical industry
- Addresses business strategy, global health challenges, and Pfizer's role in addressing major diseases